DPP4 (Dipeptidyl Peptidase-4) Inhibition Increases Catecholamines Without Increasing Blood Pressure During Sustained ACE (Angiotensin-Converting Enzyme) Inhibitor Treatment.
Jessica R WilsonErica M GarnerMona MashayekhiScott A HubersClaudia E Ramirez BustamanteScott Jafarian KermanHui NianCyndya A ShibaoNancy J BrownPublished in: Hypertension (Dallas, Tex. : 1979) (2022)
Increased catecholamines during concurrent ACE and DPP4 inhibition may contribute to cardiovascular complications in patients predisposed to heart failure.